60
Participants
Start Date
January 31, 2002
Primary Completion Date
December 31, 2005
Study Completion Date
July 31, 2006
GVAX pancreatic cancer vaccine
"Patients will receive vaccinations consisting of 5E8 vaccine cells. The first vaccination is administered 6-8 weeks after surgery. Four to eight weeks following the completion of the last cycle of adjuvant radiation and chemotherapy (chemo-radiation therapy is standard of care and not part of the protocol) eligible patients will receive three additional vaccinations at one month intervals. Patients who continue to remain disease-free will receive a fifth booster vaccination, six months following the fourth vaccination."
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
National Cancer Institute (NCI)
NIH
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER